Showing results (1-10 of 198) with videos related to
Sort By:
Pageof 20
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|June 1, 1993
[Anticoagulation in thrombolytic therapy: importance and future perspectives]J Harenberg, D L HeeneAmerican Journal of Hematology|December 1, 1988
Pharmacology and special clinical applications of low-molecular-weight heparinsJ Harenberg, D L HeeneBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Tissue factor pathway inhibitor: proposed heparin recognition regionJ Harenberg, R Malsch, D L HeeneHaemostasis|May 1, 1996
Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine GroupJ Harenberg, P Roebruck, D L HeeneSeminars in Thrombosis and Hemostasis|January 1, 1994
Binding of fluorescent-labeled low molecular mass heparin to latex microspheres and to rat and human leukocytesL Piazolo, J Harenberg, R Malsch, et al.Thrombosis Research|November 1, 1995
N' alkylamine low molecular mass heparins (LMM-heparin-tyramine and LMM-heparin-tyramine-fitc) exhibit long lasting anticoagulant effectsR Malsch, L Piazolo, J Harenberg, et al.Seminars in Thrombosis and Hemostasis|January 1, 1994
Competitive binding of low molecular mass heparin-tyramine fluorescein-5-isothiocyanate and unlabeled glycosaminoglycans to leukocytesJ Harenberg, R Malsch, L Piazolo, et al.Seminars in Thrombosis and Hemostasis|January 1, 1997
Monoclonal antibodies against heparin and heparinoidsG Huhle, J Harenberg, R Malsch, et al.Seminars in Thrombosis and Hemostasis|January 1, 1994
Comparison of three heparin bovine serum albumin binding methods for production of antiheparin antibodiesG Huhle, J Harenberg, R Malsch, et al.The Journal of Laboratory and Clinical Medicine|May 1, 1992
Microtiter assay for measurement of factor XIII activity in plasmaC E Dempfle, J Harenberg, K Hochreuter, et al.Pageof 20